Evaluating fluvoxamine for the outpatient treatment of COVID‐19: A systematic review and meta‐analysis

J Deng, M Moskalyk, QK Zuo, C Garcia… - Reviews in Medical …, 2024 - Wiley Online Library
This systematic review and meta‐analysis of randomised controlled trials (RCTs) aimed to
evaluate the efficacy, safety, and tolerability of fluvoxamine for the outpatient management of …

Exogenous shocks and MNEs: Learning from pandemics, conflicts, and other major disruptions

L Ciravegna, D Ahlstrom, S Michailova, CH Oh… - Journal of World …, 2023 - Elsevier
Exogenous shocks have long been a feature of the global economy, yet they have become
particularly salient in recent years. This Special Issue of the Journal of World Business …

COVID-19 therapeutics

D Focosi, M Franchini, F Maggi… - Clinical Microbiology …, 2024 - Am Soc Microbiol
Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options
has been studied and deployed. Healthcare providers have multiple treatment approaches …

[HTML][HTML] How health technology assessment can help to address challenges in drug repurposing: a conceptual framework

T Abu-Zahra, SE Grimm, M Scholte… - Drug Discovery …, 2024 - Elsevier
Highlights•The framework identified 20 challenges across six categories: data access,
research and development, collaboration, business case, regulatory and legal …

[图书][B] Economics of the pharmaceutical and medical device industry: Supply chain, trade and innovation

R Bhardwaj - 2024 - books.google.com
This book provides a comprehensive examination of the pharmaceutical and medical device
industry, including analysis of its current trade and innovation strategies. Opening with a …

[HTML][HTML] Rapid-response RNA-fluorescence in situ hybridization (FISH) assay platform for coronavirus antiviral high-throughput screening

R Chan, CS Mugisha, V Chuenchob, SA Moquin… - SLAS Discovery, 2024 - Elsevier
Over the past 25 years, the global community has faced challenges posed by three distinct
outbreaks of coronaviruses including severe acute respiratory syndrome coronavirus (SARS …

How can Health Technology Assessment Help in Addressing Challenges in Drug Repurposing: A Conceptual Framework

T Abu-Zahra, S Grimm, M Scholte… - …, 2024 - drugrepocentral.scienceopen.com
Drug repurposing faces various challenges that impede its success. We developed a
framework outlining key challenges in drug repurposing to explore when and how health …

[PDF][PDF] Charted territory: Evidence from mapping the cancer genome and r&d decisions in the pharmaceutical industry

JL Kao - Available at SSRN 3883041, 2021 - aeaweb.org
How does comprehensive basic scientific information shape private sector research
investments among heterogeneous firms? I assess the impact of large-scale public cancer …

[PDF][PDF] Research Developments and Understandings in the Dynamics of COVID-19: A Comprehensive Review.

A Alzahrani - International Journal of …, 2024 - jourdata.s3.us-west-2.amazonaws …
The ongoing COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2, has
spurred unprecedented research efforts worldwide. This comprehensive scientific review …

[PDF][PDF] Negative Evidence: Repurposed Drugs for COVID-19: the Partisan Bone of Contention. Part I

JM Orient - Journal of American Physicians and Surgeons, 2024 - jpands.org
Partisan conflict over the efficacy of repurposed drugs emerged as one of most divisive
elements of the highly politicized response to the COVID-19 pandemic. This dispute …